Hep Email Update
Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?
Kaiser Health News takes an in-depth look.
Advertisement
Curing Hep C Linked to Lower Risk of Liver-Related Death
This held true regardless of the type of hep C treatment—interferon-based or direct-acting antiviral.
Drug Distributors Reach $260M Deal in Ongoing Ohio Opioid Lawsuit
Three distributors and a drugmaker may avert the first federal trial over their role in the U.S. opioid crisis.
I tested positive for hepatitis C antibodies, but no one can explain why. Do you have any ideas?
Ask Hep has answers!
Hep Fall 2019
Read the latest issue!
Hep Stories: Get inspired
Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
212 W 35th St Fl 8
New York, NY 10001-2508

Add us to your address book

Copyright (C) 2019 Smart + Strong 212 W 35th St Fl 8 New York, NY 10001-2508 USA All rights reserved.
Terms Of Use and Your Privacy.